2026-06-01T02:22:39Zhttps://docta.ucm.es/rest/oai/request

oai:docta.ucm.es:20.500.14352/1142532026-01-21T01:21:19Zcom_20.500.14352_14col_20.500.14352_15

SGLT2 inhibitors in lupus nephropathy, a new therapeutic strategy for nephroprotection Morales Ruiz, Enrique Galindo Izquierdo, María 612.017 Autoimmunity Lupus Nephritis Therapeutics Ciencias Biomédicas Inmunología 32 Ciencias Médicas 2412 Inmunología Depto. de Medicina Fac. de Medicina TRUE pub 2025-01-14T12:26:57Z 2025-01-14T12:26:57Z 2022-09 journal article AO https://hdl.handle.net/20.500.14352/114253 0003-4967 10.1136/annrheumdis-2022-222512 1468-2060 eng Morales E, Galindo M. SGLT2 inhibitors in lupus nephropathy, a new therapeutic strategy for nephroprotection. Ann Rheum Dis. 2022 Aug 11;81(9):1337-1338. Attribution-NonCommercial-NoDerivatives 4.0 International http://creativecommons.org/licenses/by-nc-nd/4.0/ open access application/pdf application/pdf BMJ Publishing Group